Related Experiment Video
Updated: Jun 8, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
New treatment guidelines on Cushing's disease
Giorgio Arnaldi1, Marco Boscaro
1Division of Endocrinology, Department of Internal Medicine, Polytechnic University of Marche Region 60100 Ancona Italy.
F1000 Medicine Reports
|October 16, 2010
Summary
Rapid Cushing's disease treatment is crucial. While surgery is preferred, new pituitary tumor drugs like cabergoline and pasireotide offer hope for persistent or recurrent cases, though their clinical impact requires further study.
Area of Science:
- Endocrinology
- Neurosurgery
- Pharmacology
Background:
- Cushing's disease requires prompt treatment to mitigate long-term health risks.
- Selective transsphenoidal pituitary adenomectomy is the primary surgical approach.
- Suboptimal cure rates and high recurrence rates necessitate alternative treatment strategies.
Purpose of the Study:
- To review current and emerging treatment options for Cushing's disease.
- To evaluate the role of medical therapies in managing persistent or recurrent disease.
- To highlight novel pharmacological agents in pituitary tumor treatment.
Main Methods:
- Review of existing literature on Cushing's disease management.
- Analysis of treatment outcomes for surgical, radiological, and medical interventions.
- Discussion of the potential clinical utility of new pituitary tumor-directed drugs.
Main Results:
- Selective transsphenoidal pituitary adenomectomy has limitations regarding long-term cure and recurrence.
- Repeat surgery, radiotherapy, and bilateral adrenalectomy are options for refractory cases.
- Medical treatments, including cabergoline and pasireotide, are emerging as second-line or adjunctive therapies.
Conclusions:
- Cushing's disease management is complex, demanding a multidisciplinary and personalized approach.
- Novel pituitary tumor-directed drugs show promise but require further clinical validation.
- Cost-benefit analyses are essential for optimizing patient management strategies.
Related Concept Videos
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment: